At a recent meeting in Istanbul, the Association of Rearch-Based Pharmaceutical Companies [Araştirmaci Ílaç Firmalan Demiği (AIFD)], met to discuss developments in the fight against counterfeit drugs in Turkey and throughout the world.
Turkey is the fourth largest market for counterfeit medicines according to a speech by Cengiz Gümüştüs, head of Esfor Security Consultants and former member of the Turkish National Police and Interpol. Turkey arrests for counterfeit drugs numbered 68 in 2008. Other countries with serious problems in counterfeit pharmaceuticals are China, South Korea and Brazil.
According to Gümüştüs: “In Turkey, counterfeit drugs are marketed over the Internet, pushed by street vendors or by counterfeit drug smugglers who we call “pouchers”. Our law enforcement units are waging an effective effort against counterfeit drugs and making wide-scale raids. However, the success of this effort ultimately depends on the collaboration between the state, industry and the society.”
The Association of Research-Based Pharmaceutical Companies consists of 39 pharmaceutical companies with a focus on biotechnology and R&D, including Abbott, Actelion, Alcon, Astra Zeneca, Amgen, Astellas, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Chiesi, Daiichi-Sankyo, Eczacıbaşı–Baxter, Ferring, Fresenius Kabi, Fresenius Medical Care, Gilead, GlaxoSmithKline, İ.E. Ulagay, Indentis, Johnson & Johnson, Lilly, Lundbeck, Merck Serono, Merck Sharp & Dohme, Nestle, Novartis, Novo Nordisk, Nutricia Klinik Beslenme, Pfizer, PharmaSwiss, Pierre Fabre, Reckitt Benckiser, Sanofi Aventis, Schering-Plough, Servier, Solvay İlaç Türkiye, UCB Pharma, Wyeth, who are responsible for the greater part of new drug research worldwide.
For more information visit the AFID website at: www.afid.org.tr
Turkey is the fourth largest market for counterfeit medicines according to a speech by Cengiz Gümüştüs, head of Esfor Security Consultants and former member of the Turkish National Police and Interpol. Turkey arrests for counterfeit drugs numbered 68 in 2008. Other countries with serious problems in counterfeit pharmaceuticals are China, South Korea and Brazil.
According to Gümüştüs: “In Turkey, counterfeit drugs are marketed over the Internet, pushed by street vendors or by counterfeit drug smugglers who we call “pouchers”. Our law enforcement units are waging an effective effort against counterfeit drugs and making wide-scale raids. However, the success of this effort ultimately depends on the collaboration between the state, industry and the society.”
The Association of Research-Based Pharmaceutical Companies consists of 39 pharmaceutical companies with a focus on biotechnology and R&D, including Abbott, Actelion, Alcon, Astra Zeneca, Amgen, Astellas, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Chiesi, Daiichi-Sankyo, Eczacıbaşı–Baxter, Ferring, Fresenius Kabi, Fresenius Medical Care, Gilead, GlaxoSmithKline, İ.E. Ulagay, Indentis, Johnson & Johnson, Lilly, Lundbeck, Merck Serono, Merck Sharp & Dohme, Nestle, Novartis, Novo Nordisk, Nutricia Klinik Beslenme, Pfizer, PharmaSwiss, Pierre Fabre, Reckitt Benckiser, Sanofi Aventis, Schering-Plough, Servier, Solvay İlaç Türkiye, UCB Pharma, Wyeth, who are responsible for the greater part of new drug research worldwide.
For more information visit the AFID website at: www.afid.org.tr
Posts
